Webinar | Nestlé and Arla are leading GLP-1 food innovation. Is your R&D keeping up?​ Register Now

company svgrepo com

Synaura

Synaura manufactures, provides, and develops human milk oligosaccharides (HMO) for breastfed babies.
2022
10001+
Shanghai, Shanghai, China

Investment Funding

Last Funding Stage

Series A

Total Funding Amount

13.85M

Last Funding Date

22-10-2024

Startup Stage

Early Stage

Lead Investors

China Mengniu Dairy, Kweichow Moutai, CICC Qide, Zhongjin Qide

Something missing or incorrect on this page? Help us enrich this information